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The bioactivity of canary seed peptides (CSP) towards metabolism-regulating enzymes was evaluated. Peptides
with angiotensin-converting enzyme (ACE), dipeptidyl peptidase IV (DPP-IV), and pancreatic lipase activity
remained stable (p < 0.05) to simulated gastrointestinal digestion (SGD). CSP-SGD were transported efficiently
(>10%) through the Caco-2 monolayer, indicating absorption through the intestinal epithelium. LineweaverBurk plots demonstrated that CSP-SGD act as mixed-type inhibitors for DPP-IV and α-glucosidase. Further
more, CSP-SGD were potent as antihypertensive and antiobesity agents. Molecular docking and in silico analyses
were targeted to understand CSP-SGD interactions with ACE and pancreatic lipase. ACE-inhibitory peptides
(LHPQ, QTPHQ, KPVPR, and ELHPQ) acted as non-competitive inhibitors by destabilization of the transition
state and Zn(II) coordination in ACE. The uncompetitive inhibition of pancreatic lipase by peptides (VPPR,
LADR, LSPR, and TVGPR) destabilized the open-lid conformation of pancreatic lipase. The results of this study
showed that canary seed proteins could serve as a source of biologically active peptides.

1. Introduction
Obesity is considered a multifactorial pathology (environmental,
social, behavioral, physiologic, psychological, and genetic) that origi
nates from a disruption in the metabolic energy equilibrium, prompting
an excess in energy intake (Heitkamp et al., 2021; Ray, Mahata, & De,
2016). Westernized populations are particularly vulnerable to suffer
from obesity and overweight as a result of their social and dietary habits;
this has become evident in the last 20 years, where countries like the
USA have seen a spike from 30% to 42% in obesity (Kopp, 2019; CDC
Centers for Disease Control and Prevention, 2020). Obesity is also
considered to be the driving force towards development of chronic
diseases such as diabetes, insulin resistance, inflammation, hyperten
sion, among others (WHO, 2020b).
Chronic diseases arising from obesity could be prevented by the

inclusion of a plant-based diet (WHO, 2020a). In addition, consumer
concerns towards the use of synthetic drugs to treat chronic conditions
has driven research to focus on natural or food derived constituents that
offer similar health benefits but lack adverse side effects (Zhang, et al.,
2021). Diets rich in vegetables protect against chronic diseases by
lowering energy density, glycemic index, blood lipids, as well as
improving insulin sensitivity, endothelial function, inflammatory, and
oxidative stress conditions (Schwingshackl, Morze, & Hoffmann, 2020).
Alternatively, some biological effects (e.g., antihypertension, antidia
betic, anti-inflammatory, antiobesity, and antioxidant) have been
attributed to small molecular weight peptides originated from proteol
ysis and referred to as bioactive peptides (i.e., biopeptides). Typically,
biopeptides are 2–20 amino acids long and their activity is affected by
factors like amino acid sequence, molecular weight, hydrophobicity,
and charge distribution (Karami & Akbari-Adergani, 2019; Zhang, et al.,
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2021). Plant biopeptides could help decrease the incidence of hyper
tension, obesity, and diabetes by modulating key enzymes (e.g., ACE,
DPP-IV, pancreatic lipase) that participate actively in specific pathol
ogies (Daskaya-Dikmen, Yucetepe, Karbancioglu-Guler, Daskaya, &
Ozcelik, 2017; Kumar, Narwal, Kumar, & Prakash, 2011; Sánchez &
Vázquez, 2017). For instance, biopeptides from hemp, quinoa, and
common bean have shown inhibitory activity against angiotensin con
verting enzyme (ACE), dipeptidyl peptidase IV (DPP-IV), α-glucosidase,
and pancreatic lipase (Awosika & Aluko, 2019; Nongonierma, Le Maux,
Dubrulle, Barre, & FitzGerald, 2015; Orio et al., 2017; Vilcacundo,
Martínez-Villaluenga, & Hernández-Ledesma, 2017). In this context,
emerging or novel plants with high protein content are of particular
interest to scientists as they could represent a high source of biopeptides
and could be used to formulate functional foods and nutraceuticals.
Hairless canary seed (Phalaris canariensis L.) is considered as a novel
plant with high protein content (19–24%) used in traditional medicine
to treat various chronic diseases (Valverde, Orona-Tamayo, NietoRendón, & Paredes-López, 2017). For example, they have served as a
traditional remedy in Mexico to treat obesity, diabetes, and hyperten
sion (Estrada-Salas, Montero-Morán, Martínez-Cuevas, González, &
Barba de la Rosa, 2014), supporting their potential application for
human consumption as a novel food ingredient (Patterson, et al. 2018,
Mason, L’Hocine, Achouri, & Karboune, 2018). Preliminary research
from our group has indicated that biopeptides from the proteolysis of
canary seed protein have the ability to inhibit enzymes (α-glucosidase,
ACE, DPP-IV, and pancreatic lipase) (Urbizo-Reyes, Aguilar-Toalá, &
Liceaga, 2021). The ability of biopeptides to exert an effect in vivo de
pends strongly on their gastrointestinal stability and their ability to cross
the intestinal epithelium (Bhandari et al., 2020). So far, information
involving the specific peptide sequences, bioavailability, and the mo
lecular interactions (peptide-enzyme) of canary seed biopeptides is un
known. Therefore, the aim of this study was to evaluate the in vitro
gastrointestinal stability and bioavailability of canary seed peptides,
identify the peptides sequences involved in biological activities, and
understand their mechanism of action using enzyme kinetics and mo
lecular docking strategies. In this study, we assessed the bioactivities of
simulated gastrointestinal digested canary seed peptides, implemented
enzyme kinetics, and fractionated the peptides. In silico analysis of
identified fractions was applied to identify relevant structural charac
teristics and the molecular interaction of these biopeptides (ligands)
with their most potent receptors (ACE and pancreatic lipase).

International (Radnor, PA, USA), Millipore Sigma (St. Louis, MO, USA),
and Thermo Fisher Scientific (Waltham, MA, USA).
2.2. Preparation of canary seed peptides (CSP) and simulated
gastrointestinal digestion (SGD)
Canary seeds were defatted by cold mechanical oil extraction (37 ±
2 ◦ C), crushed, and hydrolyzed following the methodology detailed by
Urbizo-Reyes et al. (2021). Briefly, defatted canary seed powder was
diluted (22.5 mg of protein/mL) and homogenized in deionized water
using Sorvall Omni Mixer with a macro-attachment assembly (Norwalk,
CT, USA). The solution’s pH was adjusted to 8.0 with 2 M NaOH and
preheated to 50 ± 3 ◦ C followed by hydrolysis for 4 h with 3% (w/w)
Alcalase®. Hydrolysis was terminated by heat treatment (95 ± 3 ◦ C) for
15 min. The solution was cooled and centrifuged (17,636g for 15 min)
(Avanti J-26S Centrifuge, Beckman-Coulter INC. CA, USA). The super
natant was collected as soluble peptides and stored at − 80 ◦ C until use.
Next, the peptides were subject to simulated gastrointestinal diges
tion (SGD) using a modified method described by Minekus et al., (2014).
Briefly, the peptides solution (10 mg of protein/mL) was adjusted to pH
2.0 using 1 M HCl and incubated with pepsin (4% w/w of protein) at
37 ◦ C for 2 h. Then, 0.9 M NaHCO3 was used to adjust pH to 5.3, and 1.0
M NaOH to further increase the pH to 7.5. Pancreatin was then added
(4% w/w of protein), and the mixture incubated at 37 ◦ C for 2 h. The
digestion was terminated by pasteurization (95 ± 3 ◦ C) for 15 min.
Subsequently, the solution was cooled to room temperature and
centrifuged at 11,000g for 15 min; the supernatant was collected and
referred to as digested peptides. Preliminary studies showed that small
peptides (<3 kDa) from canary seed were the most biologically active
(Urbizo-Reyes et al., 2021). For this reason, peptides were fractionated
by ultrafiltration using a <3 kDa cutoff membrane and referred to as
canary seed peptides (CSP) and CSP after simulated gastrointestinal
digestion (CSP-SGD), respectively. Lastly, CSP and CSP-SGD were frozen
at − 80 ◦ C for 12 h and freeze-dried using a Labconco FreeZone Plus 2.5 L
cascade benchtop freeze dry system (Labconco Corp., Kansas City, MO).
The powders were stored at 4 ± 1 ◦ C until analysis. The peptide content
was normalized using the bicinchoninic acid (BCA) protein assay
(Thermo Scientific, Rockford, IL, USA) before subsequent analysis.
2.3. α-Glucosidase inhibitory activity

2. Materials and methods

The inhibition of α-glucosidase activity was determined as described
by Sultana et al., (2020). Initial, α-glucosidase was extracted by solu
bilizing 300 mg of intestinal acetone powder from rat in 9 mL sodium
chloride solution (0.9% w/v) and vortexed for 5 min. Then, the solution
was centrifuged at 12,500g for 5 min, the supernatant was recovered and
used as a source of α–glucosidase (8.33 mg/L). Briefly, a 50 µL aliquot of
sample suspended in 0.1 M sodium phosphate buffer (pH 6.9) was
pipetted into a 96-well microplate, with 50 µL of α-glucosidase, followed
by a pre-incubation for 10 min at 37 ◦ C. Next, the reaction was initiated
by pipetting 100 µL of 4-nitrophenyl α-D-glucopyranoside (5 mM). The
inhibition was calculated spectrophotometrically using Multiskan™ FC
Microplate Photometer (Waltham, MA, USA), reading the absorbance at
405 nm for 30 min. Acarbose was used as a reference. The percentage
inhibition was calculated using equation [Eq. (1)].

2.1. Materials
Hairless canary seeds (CDC Cibo) were purchased from a commercial
vendor (Can-pulse Foods LTD, Saskatoon, SK, Canada). Alcalase®
(protease from Bacillus licheniformis), was purchased from Novozymes
(Bagsvaerd, Denmark). Pancreatic lipase (Type VI-S ≥ 20,000 units/mg
protein, EC 3.1.1.3), rat intestinal acetone powder (α-Glucosidase, EC
3.2.1.20), angiotensin-converting enzyme (ACE; ≥10 units/mg protein,
EC 3.4.15.1), dipeptidyl peptidase-IV (DPP-IV, ≥ 4500 units/ µg protein,
EC 3.4.14.5) and their substrates oleic acid 4-methylumbelliferyl ester,
p-nitrophenyl-α-d-glucopyranoside, Gly-Pro p-nitroanilide hydrochlo
ride, and hip-puryl-L-histidyl-L-leucine (HHL), respectively, were all
purchased from Millipore Sigma (St. Louis, MO, USA). Caco-2 cells were
purchased from Millipore Sigma (St. Louis, MO, USA). Chemicals and
materials not specified above were purchased from companies VWR

α-glucosidase inhibition (%) = 100 × [

Abs Control (no inhibitor) − Abs Sample
)]
(Abs Control (no inhibitor)

2

(1)

U. Urbizo-Reyes et al.

Journal of Functional Foods 88 (2022) 104892

2.4. Determination of ACE inhibitory activity

using equation [Eq. (3)].

ACE-inhibitory activity was measured according to the method
described by Urbizo-Reyes, et al. (2019). Peptide samples (CSP and CSPSGD) were dissolved in phosphate buffer (100 mM, pH 8.3) with 300
mM sodium chloride. Aliquots (25 µL) of peptide sample solutions were
added to 25 µL of the substrate hippuryl-L-histidyl-L-leucine (HHL) and
incubated at 37 ◦ C for 4 min. Aliquots (80 µL) of human-ACE (50 mU)
were added to initiate the reaction, followed by incubation at 37 ◦ C in a
water bath with constant stirring for 2 h. The reaction was terminated by
adding 50 µL of 1 M HCl and diluted by adding 50 µL of acetonitrile
solution with 1% (v/v) trifluoroacetic acid (TFA) and 50 µL of distillated
water with 1% (v/v) TFA. A control reaction was performed using 25 µL
of the buffer instead of the inhibitor (CSP). Hippuric acid (HA) was
quantified using high-pressure liquid chromatography (HPLC) (Model
600E, Waters Corporation, Milford MA) with a C18 analytical column
(YMC Pack ODS AM 12505-2546 wt, YMC America, Inc., Allentown, PA,
USA). The commercial drug captopril was used as positive control.
Finally, percent inhibition was calculated using equation [Eq. (2)].

2.7. Mode of inhibition using enzyme kinetics

ACE inhibition (%) = [1 −

A inhibitor
] × 100
A control

The mode of enzyme inhibition was calculated by measuring the
inhibitory capacity of CSP-SGD peptides at various substrate concen
trations and calculating the initial reaction velocities from the product
formation over time (Hall et al. 2018). The CSP-SGD and the substrates
concentrations used in this study were: (0, 4 and 8 mg/mL) of CSP-SGD
and (0.625, 1.25 2.5 and 5 mM) of 4-nitrophenyl for α-D-glucopyrano
side α-Glucosidase; (0, 0.5 and 1 mg/mL) of CSP-SGD and (1.25, 2.5, 5,
10 mM) of HHL for ACE; (0, 5, and 10 mg/mL) of CSP-SGD, and (2, 4, 6,
and 8 mM) of Gly-Pro p-nitroanilide hydrochloride for DPP-IV; (0, 1, and
2 mg/mL) of CSP-SGD, and (1, 2, 3 and 4 mM) of 4-methylumbelliferyl
oleate for pancreatic lipase. Enzyme inhibition (%) was measured as
described above. Reaction velocities were determined from the forma
tion of the product over time as (ΔAbs/min) or (Δarea/min). Finally,
Km, Vmax and type inhibition were assessed by Lineweaver-Burk graphs
using the reciprocal of product concentration versus the reciprocal of
substrate concentration at various CSP-SGD concentrations.

(2)

2.8. Reverse-Phase-High-Performance-Chromatography (RP-HPLC)

where A_inhibitor and A_control represent the relative areas (A) with and
without inhibitor of the HA peaks.

CSP-SGD were further purified utilizing as detailed by Nuchprapha
et al. (2020). Briefly, CSP-SGD was suspended in HPLC grade deionized
water and filtered (0.45 µm). A volume of 50 µL of CSP-SGD (7 mg
protein/mL) was injected at 25 ◦ C to a XBridge™ BEH130 C18 column
(10 μm, 10 × 150 mm, Waters Inc., Milford, MA, USA) using a two-stage
gradient procedure: starting with an eluent concentration of 100:0% (v/
v) A: B decreasing to 75:25% (v/v) A: B over 35 min, and then to 60:40%
(v/v) A:B over 60 min, at a flow rate of 0.3 mL/min. Mobile phase A
consisted of HPLC grade deionized water with 0.1% (v/v) TFA, while B
was HPLC grade acetonitrile with 0.1% (v/v) TFA. The process was
carried out using a Waters 2690 HPLC system (Waters Corporation,
Milford, MA, USA), equipped with an automatic sample injector and
2998 UV photodiode array (PDA) detector. The elution of peptide
fractions was monitored at a wavelength of 280 nm. The eluted fractions
(F1-F7) (Supplementary Materials Fig. 1S) were collected, concentrated,
and stored at –80 ◦ C until analysis. Based on the results of sections
2.3–2.7, the fractions were further tested for their most potent biological
properties (ACE and pancreatic lipase inhibitory activities).

2.5. Dipeptidyl peptidase IV (DPP-IV) inhibitory activity
The DPP-IV inhibitory activity of the samples was determined
following the method by Hall et al. (2018). Briefly, 25 µL of the peptide
samples dissolved in 100 mM Tris-HCl buffer (pH 8.0) were preincubated in a 96-well microplate with 25 µL of substrate Gly-Pro pnitroanilide hydrochloride (6 mM) at 37 ◦ C for 10 min. Then, 50 µL of
human DPP-IV (4.5 U/mL) was added, followed by incubation at 37 ◦ C
for 60 min. The reaction was stopped by adding 100 µL of 1 M sodium
acetate buffer (pH 4.0). Absorbance of released p-nitroanilide was
measured at 405 nm using a Multiskan™ FC Microplate Photometer
(Waltham, MA, USA). The sample blank (no inhibitor) used buffer
instead of the sample. For the negative control (no DPP-IV activity), the
buffer was used instead of DPP-IV solution. Percent DPP-IV inhibition
was calculated using equation [Eq. (3)].
[
]
(Abs sample − Abs sample blank)
Inhibition (%) = 1 −
(Abs positive control − Abs negative control)

2.9. Transport study using Caco-2 monolayer

× 100

The bioavailability of the CSP-SGD was evaluated according to Dueik
and Bouchon (2016). CSP-SGD were centrifugated, and the supernatant
filtered using a 0.45 μm syringe filter. The supernatant was used to
assess the transport across intestinal epithelial cells. Briefly, Caco-2 cells
(22–27 passages) were grown in tissue culture flasks with Eagle’s Min
imum Essential Medium (EMEM) supplemented with 10% fetal bovine
serum, 100 U/L of penicillin, 50 µg/ml gentamicin (CMEM), 100 µM of
non-essential amino acids, and 100 U/L of streptomycin. Cells were
grown at 37 ◦ C under an atmosphere containing 5% CO2. The medium
was changed every 2- days, and the cells sub-cultured weekly by trypsinEDTA treatment. Then, the monolayer was developed by seeding in 6well high pore density polyethylene terephthalate inserts at a density
of 2.5×105 cells per cm2 and growing the cells for 20–21 days, replacing
the medium every 2 days. The permeability of lucifer yellow (0.1 mg/
mL) was measured before and after the experiment, and only wells with
a permeability below 3% were used in the experiment. Next, the cells
were washed twice using HBSS buffer (pH 7.2) and incubated for 30 min
each time before starting the experiment. Finally, the CSP-SGD was
added to the apical layer at a concentration of 4.5 mg/mL and incubated
as described above. After 2 h, samples from the apical and basolateral
layers were collected and freeze-dried. The apical (50 μL) and baso
lateral (50 μL) constituents were injected into an analytical C18 column.

(3)
2.6. Pancreatic lipase inhibition
Pancreatic lipase inhibition activity was measured following the
methodology by Zhu et al. (2014) with modifications. Briefly, samples,
substrate, and pancreatic lipase were dissolved in McIlvaine buffer (0.1
M Citrate-Na2HPO4, pH 7.4). Then, 50 µL of substrate 4-methyl
umbelliferyl oleate (1 mM) was pre-incubated with 25 µL of peptide
sample for 10 min in a black 96-well microplate. The reaction was
started by adding 25 µL of pancreatic lipase type-VI (200 U/mL) and
carried out for 1 h. The production of 4-methylumbelliferone was
measured fluorometrically using a Fluoroskan Ascent FL Microplate
Fluorometer and Luminometer (ThermoFisher Scientific, Waltham, MA,
USA) using an excitation wavelength of 355 nm and emission wave
length of 460 nm. Sample absorbance was corrected by subtracting
blanks in which pancreatic lipase was replaced with McIlvaine buffer.
The sample blank (no inhibitor) used the buffer instead of the sample.
Instead of pancreatic lipase solution, the buffer was used as negative
control (no pancreatic lipase activity) and the commercial drug orlistat
was used as the positive control. Finally, lipase inhibition was calculated
3
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Samples were analyzed by RPH-HPLC, eluted using a linear gradient of
acetonitrile (0–60% in 30 min) and 0.1% TFA in H2O at a flow rate of
0.5 mL/min, at an absorbance of 214–280 nm. The transport percentage
was calculated by measuring the peak areas of the original test peptides
(apical) and the overall amount of the original peptide plus degradation
products transported through the monolayers (basolateral).

best-ranked docking modes (Supplementary Materials Table 1S and 2S)
were selected according to the affinity energy values, and peptideenzyme interaction figures were analyzed and developed using Discov
ery Studio 2021 visualizer (Accelrys Software Inc., San Diego, CA, USA;
Discovery Studio Modeling Environment, Accelrys Software Inc., San
Diego, CA, USA, 2016).

2.10. Identification of ACE and pancreatic lipase inhibitory peptides

2.12. Statistical analysis

The most active peptide fraction was selected for tandem-mass
spectrometry (LC-MS/MS) and de novo sequencing in collaboration
with the Proteomics Core facility at the Indiana University School of
Medicine (Indianapolis, Indiana, USA) following methods described by
Hall, Reddivari, and Liceaga (2020). Briefly, 200 µg of CSP-SGD (from
fraction F7) were suspended in 100 µL 0.1% formic acid, then 10 µL were
injected into a 5 cm trap column and a 15 cm (2 µm particle size, 50 µm
diameter) EasySpray (801A) column on an UltiMate 3000 HPLC and QExactive Plus (ThermoFisher Scientific, Walthman, MA, USA) mass
spectrometer. Data analysis was performed using the PEAKS Xpro de
novo software (Bioinformatics Solutions). Only peptides with de
Average Local Confidences scores > 80% were selected to be further
processed for molecular docking analysis. The Thermo Fisher Peptide
analyzing tool server (available at https://www.thermofisher.com/us/e
n/home/life-science/protein-biology/peptides-proteins/custom-pepti
de-synthesis-services/peptide-analyzing-tool.html) was utilized for
determination of physiochemical properties (e.g., GRAVY, hydropho
bicity, PI) of identified peptides and BIOPEP-UWM server (http://www.
uwm.edu.pl/biochemia/index.php/en/biopep) was implemented for
database search for bioactive peptide sources (Minkiewicz, Iwaniak, &
Darewicz, 2019). Then, ACE inhibitory peptides were further filtered by
in silico prediction algorithms of antihypertensive peptides using the
AHTPin online server at (available at http://crdd.osdd.net/raghava/ah
tpin/) for antihypertensive potential using a scoring function, where a
score above 0 indicates the peptide has antihypertensive potential and
score below 0 indicates poor antihypertensive potential (Bounouala,
Roudj, Karam, Recio, & Miralles, 2017). Based on this scoring (SVM >
0.9) the best 30 peptides were selected for molecular docking analysis.
Similarly, pancreatic lipase inhibitory peptides were subject to a second
round of filtration based on literature criteria in the following scheme:
arginine content in peptide sequence (Stefanucci et al., 2019), and hy
drophobic amino acid score (Mudgil, Kamal, Yuen, & Maqsood, 2018),
thus, selecting the top 20 peptides for molecular docking analysis.

The results in this study were analyzed using a complete randomized
design, analyzed with a One way-ANOVA under Tukey (p < 0.05) by the
statistical software SAS 9.4® (Cary, NC, USA). Results were reported as
mean ± standard deviation (SD) of triplicate determinations.
3. Results and discussion
3.1. Impact of SGD on enzyme inhibition capacity
Previously, we demonstrated that canary seed peptides (CSP) with
molecular weight < 3 kDa showed high potential for biological activity
towards enzymes related to obesity, diabetes, hypertension, and oxida
tive stress (Urbizo-Reyes et al., 2021). This bioactivity has been reported
in other plant proteins and attributed to the exposure of aromatic,
charge, and hydrophobic amino acids that are liberated from the protein
core that react with these enzymes (Ketnawa, Suwal, Huang, & Liceaga,
2018; Nongonierma, et al., 2015; Urbizo-Reyes et al., 2019). To un
derstand the bioactive stability of CSP to gastrointestinal digestion, the
inhibitory activity of < 3 kDa CSP and CSP after simulated gastroin
testinal digestion (CSP-SGD) fractions was tested against chronic
disease-related enzymes such as α-glucosidase, ACE, DPP-IV and
pancreatic lipase. After SGD, the half-maximal inhibitory (IC50) con
centration increased (p < 0.05) for α-glucosidase from 1.15 to 1.47 mg/
mL (Fig. 1). These results are similar to those reported for peptides
produced by hydrolysis with Alcalase of orange seed (Siavaraze, Citrus
sinensis) and hemp seeds (Cannabis sativa L), which showed a decrease in
α-glucosidase inhibition after SGD (Mazloomi et al., 2020; Ren et al.,
2016). This could be a result of the digestion of the active peptide
fractions, causing a loss in bioactivity. In silico tools corroborated this
theory, showing that peptides from different sources (including Asper
gillus awamori, albumin, and egg white protein) with high to moderate
α-glucosidase inhibitory activity were unstable to gastrointestinal
digestion (Ibrahim, Bester, Neitz, & Gaspar, 2018).
Conversely, this was not the case for ACE and DPP-IV inhibition,
where there was no significant change observed for inhibition of ACE
and DPP–IV after SGD, indicating gastrointestinal stability. Based in the
in silico analysis, the ACE inhibitory peptides identified from the CSP-

2.11. Molecular docking of canary seed biopeptides
Molecular docking was performed with AutoDock Vina as previously
described by Hall et al. (2020). BIOVIA Discovery Studio® 4.5 Visualizer
(BIOVIA Corporate Americas, San Diego, CA, USA) was utilized to
construct CSP-SGD peptides, then charges were added to the molecules
and the optimal conformations were identified by energy minimization
by Merck Molecular Force Field (MMFF94) utilizing ChemBiodraw 3D
(PerkinElmer, MA, USA). Discovery Studio software and AutoDock4
(4.2.6) were used for enzyme preparation prior to docking and to
visualized peptide-protein interactions (Trott, & Olson, 2010). First,
ACE (PDB ID: 1O8A) and pancreatic lipase (PDB ID: 1ETH) 3D crystal
structures were prepared for docking by removing Linosinopril,
hydroxyethyloxy triethyloxy, and water molecules (Hermoso, Pignol,
Kerfelec, Crenon, Chapus, & Fontecilla-Camps, 1996; Natesh, Schwager,
Sturrock, & Acharya, 2003). Then polar hydrogen atoms and cofactors
like Zn2+ interacting with E411 D415 H383 and H387 and chloride ions
were added when applicable, then the binding sites coordinates were
defined as x = 41.194, y = 33.848, z = 46.304 with a radius of 60 Å for
ACE, and x = 71.524, y = 26.883, z = 187.849 with a radius of 60 Å for
pancreatic lipase. Inhibitor drugs orlistat and captopril were down
loaded from the drug bank website (https://www.drugbank.ca/) and
utilized as positive control for molecular docking analysis. Then, the

Fig. 1. α-Glucosidase, ACE, DPP-IV, and pancreatic lipase inhibition of canary
seed peptides (CSP) and canary seed peptides after simulated gastrointestinal
digestion (CSP-SGD). Bars represent mean values of triplicate determinations ±
standard deviation. Asterisks (*) indicate statistical differences (p < 0.05) be
tween CSP and CSP-SGD.
4
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SGD had a high content of proline residues in their last and penultimate
position (Supplementary Materials Table 1S). This characteristic is re
ported to make peptides less susceptible to proteolytic enzymes,
allowing them to resist gastrointestinal digestion (Hall et al., 2020).
Similarly, amino acid composition and chain length could have pre
vented DPP-IV inhibitory peptides from degrading during SGD. This
hypothesis is supported by studies conducted on collagen (Wang et al.,
2021) and whey (Nongonierma & FitzGerald, 2013) peptides, where
factors like small molecular weight (4–5 amino acids), and intermediate
proline content increased the tendency of DPP-IV inhibitory peptides to
resist gastrointestinal digestion. Additionally, the specific positioning of
rigid amino acids like proline near aromatic and basic amino acids can
confer a peptide resistance to digestion by pepsin and trypsin (De
Angelis, et al., 2021). This study’s DPP–IV inhibition results (1.24 mg/
mL) also align with those reported by Estrada-Salas et al. (2014) for
peptides from canary seed; however, the ACE inhibition of the CSP-SGD
was much higher (0.037 mg/mL) than those reported by Estrada-Salas
et al. (2014) for canary seed peptides after gastrointestinal digestion
(0.332 mg/mL).
The IC50 values for pancreatic lipase inhibition decreased (p < 0.05)
after SGD (Fig. 1). Stefanucci et al. (2019) discovered that arginine-rich
proteins highly inhibit this lipase. In agreement with this, canary seed
protein has a notoriously high content of arginine (6.4%, w/w dry basis
of protein) when compared to other cereals like wheat (5.1%), oat
(5.79%), barley (4.6%), and millet (3.9%) (Mason, L’Hocine, Achouri, &
Karboune, 2018). Furthermore, the proximity of arginine to the C-ter
minal of the peptide chain could increase pancreatic lipase inhibitory
capacity (Stefanucci et al., 2019). In this context, peptides subject to
gastrointestinal digestion increased their activity due to the exposure of
arginine residues in the last and penultimate position of their amino acid
chain (Supplementary Materials Table 2S). This event is caused by the
digestion with trypsin, which cleaves C-terminal arginine, and lysine,
yielding a high abundance of arginine in the aforementioned sites.
Overall, these results indicate that canary seed peptides hold good bio
logical activity even after being exposed to gastrointestinal conditions,
and could potentially serve as functional or nutraceutical ingredients.

inhibition of the CSP-SGD biopeptides by assessing the α-glucosidase,
ACE, DPP-IV, and pancreatic lipase inhibition at various peptide and
substrate concentrations (Fig. 2). Data showed that the Km (x-axis) of the
α-glucosidase and DPP-IV changed while the Vmax (y-axis) decreased as
the CSP-SGD concentration increased; this indicates that CSP-SGD acted
mainly as mixed-type inhibitors. In the case of ACE, we can observe no
changes in Km, but a drop in Vmax as the peptide concentration increased;
this indicates that the peptides act as non-competitive inhibitors. Sur
prisingly, an increase in CSP-SGD seemed to cause a decrease in both Km
and Vmax for pancreatic lipase, resulting in a parallel pattern on the
plots, associated with an uncompetitive inhibition (Moreno-Córdova
et al., 2020).
Until now, there was no information on the mode of inhibition of
peptides from canary seed towards chronic disease-related enzymes
(α-glucosidase, DPP-IV, ACE, and pancreatic lipase). The LineweaverBurk double reciprocal plots indicated that CSP-SGD acted as mixedtype inhibitors for α–glucosidase and DPP-IV. Mixed type inhibitors
affect the binding of the substrate and the velocity of catalysis of the
enzymatic reaction, allowing the peptides to bind to both free enzyme
and substrate-enzyme complexes with slight variation in affinity en
ergies (Ring, Wrighton, & Mohutsky, 2014). For ACE, the outcomes
indicate a non-competitive type of inhibition. Non-competitive in
hibitors usually have a reversible binding nature and does not affect the
substrate-binding process, as they could act on various sites to induce
conformational changes that affect enzyme activity (Ring et al., 2014).
Conversely, CSP-SGD displayed an un-competitive mode of inhibition
towards pancreatic lipase. This mechanism of action relies on the in
hibitors binding only to enzyme-substrate complexes, inducing confor
mational stages that prevent the enzyme from functioning correctly
(Ring et al., 2014).
3.3. Transport study, ACE and pancreatic lipase inhibition of CSP-SGD
peptide fractions
To further understand the biological potential of CSP for human
health, we assessed their transport through the epithelium, stability to
gastrointestinal digestion, and determined amino acid sequence of the
most active peptide fraction. RP-HPLC was used to separate CSP-SGD
into seven fractions (Supplementary Materials Fig. 1S). The percent
age inhibition of ACE and pancreatic lipase and the transport across

3.2. Mode of inhibition of CSP-SGD
Lineweaver–Burk plots were created to determine the mode of

Fig. 2. Lineweaver-Burk plot of α-Glucosidase, ACE, DPP-IV and pancreatic lipase enzymes by canary seed peptides after simulated gastrointestinal digestion
(CSP-SGD).
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Fig. 3. Transport (%) of canary seed peptide fractions (F1-F7) across Caco-2 monolayer (A) after simulated gastrointestinal digestion (CSP-SGD), and their inhibition
activity against ACE (B), and pancreatic lipase (C). Peptide fractions were collected by RP-HPLC (normalized to a protein concentration of 35 µg/mL). Bars represent
mean values of triplicate determinations ± standard deviation. Different letters (A-F) indicate statistical differences (p < 0.05) between fractions.

Caco-2 monolayer for CSP-SGD fractions F1-F7 are shown in Fig. 3. All
CSP-SGD fractions had a bioavailability > 10% (Fig. 3A), with higher (p
< 0.05) capacity to be transported observed for fraction F5 (23.64%)
and F7 (21.89%), followed by F4, F3, F2, F1, and the lowest transport for
F6. Caco-2 permeation leads to the formation of new peaks and peak
shoulders that might be the product of cellular digestion (Supplemen
tary Materials Fig. 2S). It is known that peptides can be transported via
the PepT1 and paracellular transport pathways through the intestinal
epithelium, where factors like charge, hydrophobicity, composition, and
position of the amino acids could impact their transport rates (Wang,
Xie, & Li, 2019). For instance, scientific literature reports that peptides
with different chain lengths can be absorbed through different routes
such as PepT1-mediated transport for di- and tri-peptides, the passive
paracellular route for oligopeptides with < 8 amino acids, and the
transcytosis route for long-chain peptides with < 10 amino acids
(Aguilar-Toalá & Liceaga, 2021; Xu, Hong, Wu, & Yan, 2019). The small
molecular weight of the peptides identified in this study (316–1753 Da)
(Supplementary Materials Table 3S) and the differences in hydropho
bicity profile of the peptide fractions (F1-F7) could contribute to the
observed transport yields. For example, peptides (1437 Da) from bovine
milk permeated up to 38% through Caco-2 monolayer (Picariello et al.,
2013). In another study, oligo peptides from collagen with molecular
weights (1000 and 200 Da) permeated around 13% and 23%, respec
tively (Song, Tian, & Li, 2020). In the case of hydrophobicity, this could
have accounted for the high transport rate of F7. From this respect, it is
reported that highly hydrophobic peptides bind firmly to PepT1
(Newstead, 2015). The positive correlation of peptide hydrophobicity
with permeability across the Caco-2 monolayer has been widely vali
dated in literature (Bao, Zhao, Wang, Chi, & Technology, 2017; Xie,
Wang, Jiang, Liu, & Li, 2015). Hydrophobic peptides are likely trans
ported by diffusion and their counterparts by carrier-mediated and
energy-dependent processes that could facilitate their transport and
rationalize the intensification of transport yields for sequences eluting
last during RP-HPLC (Xie et al., 2015).
The bioactivity of the peptide fractions increased as the elution
progressed, and all collected fractions displayed high capacity to inhibit
ACE and pancreatic lipase (>40%), except for fractions F1 and F2
(Fig. 3B). As expected, the positive control captopril (1 µg/mL) showed a
significantly (p < 0.05) higher inhibition capacity (94%) towards ACE
than any other peptide fraction. Nevertheless, fractions F7 and F5 (35
µg/mL) were the most active (p < 0.05), inhibiting ACE by 64% and
60%, respectively. Similarly, F7 (35 µg/mL) had the highest (p < 0.05)
pancreatic lipase inhibitory activity (92%) and in this case, it was as
effective as the positive control orlistat (1.2 ng/mL) with 96% inhibition
(Fig. 3C). This observation is believed to be a result of the higher content
of hydrophobic peptides present in latter eluted fraction (F7) (Supple
mentary Materials Table 3S). Hydrophobicity has shown to be a relevant
structural parameter that could modulate a peptide’s biological activity

(Karami & Akbari-Adergani, 2019). It is known that peptides separated
with RP-HPLC result in hydrophobic peptide fractions being eluted last
(Montone, et al., 2019). Likewise, studies on sunflower, (Megías et al.,
2009), wheat (Liu et al., 2021), and longan seeds (Nuchprapha et al.,
2020) have demonstrated similar results, where fractions separated with
RP-HPLC that eluted last had the highest biological activity. To gain
mechanistic insights of the CSP-SGD interaction with ACE and pancre
atic lipase, we used LC-MS/MS analysis and a molecular docking
simulation of the most active fraction (F7).
3.4. Identification and molecular docking analysis of CSP-SGD with ACE
inhibition
About 56% of the peptides from fraction F7 were predicted to exhibit
antihypertensive potential (SVM score > 0.0), and 69 peptides showed
high antihypertensive potential (SVM score > 0.9), of which the four
peptides (LHPQ, QTPHQ, KPVPR, and ELHPQ) with the highest binding
activity towards ACE are shown in Fig. 4. Database search using BIOPEPUWM online server (http://www.uwm.edu.pl/biochemia/index.php/
en/biopep, accessed 5/28/2021) revealed that canary seed peptides
had in their sequences di- and tri-peptides previously reported with
ACE-inhibitory activity (e.g., PLP, VPP, HL, HP, QP, and KP) (Minkie
wicz, Iwaniak, & Darewicz, 2019). These four peptide sequences had
binding energies (Affinity Energy) ranging from − 8.9 to − 8.0 kJ/mol,
negative GRAVY (average hydrophobicity and hydrophilicity) scores
(− 2.5 to − 1.1) indicating high hydrophobicity, and holding interactions
sporadically with 11 main residues of the ACE structure (Table 1).
Overall, CSP-SGD (F7) interacted with ACE residues mainly by hydrogen
bonding, followed by Van der Waals, and hydrophobic interactions with
a lower contribution of metal bonding, and electrostatic interaction by
salt bridges. Molecular docking analysis revealed inhibitory motifs of
CSP-SGD (F7), which were especially rich in proline, glutamine, and
cationic residues (lysine and histidine) (Fig. 4 and Supplementary Ma
terials Table 1S).
Proline-rich peptides LHPQ and KPVPR exhibited hydrophobic in
teractions, playing an essential role in the interaction with ALA 354,
HIS353/383, PHE457, and VAL380. Glutamine-rich peptides QTPHQ
and ELHPQ interacted in a higher frequency by hydrogen bonding and
salt bridges (electrostatic interactions) with ALA354, ASN277, GLN281,
GLU162/384, HIS353/513, LYS511, and ZN (II) with a significant role
in the peptide enzyme interaction. In the case of cationic residues
(lysine, arginine, and histidine), they interact mainly by conventional
hydrogen bonding with a less frequent amount of electrostatic and hy
drophobic interactions with ALA354, ASP453, GLU162, HIS353/513,
and VAL379/380 (Fig. 4).
The hydrophobic amino acid proline and its proximity to the C-ter
minal has been directly associated with ACE-inhibition (Ianzer et al.,
2007; Hall et al., 2020). This agrees with the results observed in our
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Fig. 4. Interaction of four canary seed peptide sequences (A-D) with the highest binding energy towards angiotensin converting enzyme (ACE).
Table 1
Binding energies and interacting residues of docked canary seed peptides identified by LC-MS/MS.
ACE inhibitory peptides

Pancreatic lipase inhibitory peptides

Peptide attribute

LHPQ

QTPHQ

KPVPR

ELHPQ

Peptide attribute

Affinity Energy (kJ/mol)
de novo Score (%)
Mass (Da)
Hydrophobicity
GRAVY
ACE interacting residues
ALA354
GLU162
GLU384
GLU411
HIS353
HIS383
HIS513
LYS511
TYR523
VAL380
ZINC (II)

− 8.9
96
493.6
4.8
− 1.1

− 8.6
86
609.7
2.3
− 2.5

− 8.2
87
595.8
5.1
− 1.5

− 8.0
89
622.7
5.9
− 1.6

+
−
+
−
+
+
+
−
+
+
−

+
+
+
−
+
+
+
+
+
−
+

+
+
+
+
+
+
+
+
+
+
−

+
−
+
−
+
+
+
+
+
+
+

Affinity Energy (kJ/mol)
− 6.2
de novo Score (%)
92
Mass (Da)
454.3
Hydrophobicity
3.0
GRAVY
− 0.9
Pancreatic lipase interacting residues (Step
ASP248 (S1)
+
ASP250 (S1)
+
ASP258 (S1)
+
CYS238 (S2)
−
LYS240 (S2)
+
GLY237 (S3)
−
ILE249 (S4)
+
Colipase interacting residues
ASP12
−
GLN239
−
GLU13
−
GLU15
−

VPPR

LADR

LSPR

TVGPR

− 6.0
97
494.2
2.4
− 0.6
1–4)1
+
−
+
−
+
−
+

− 6.0
95
484.3
5.5
− 0.8

− 5.9
85
442.2
4.3
− 0.6

+
+
+
−
+
−
+

−
−
−
+
−
+
−

−
−
−
−

−
−
−
−

+
+
+
+

+ or − symbols indicate presence or absence of the interaction, respectively.
1
(S1–S4): indicate the four pancreatic lipase lid conformational steps in which the residues participate during hydrolysis of triglycerides.

study where CSP–SGD had a high content of proline principally in the
middle or penultimate position and with cationic amino acids (histidine,
lysine, and arginine) at a foremost frequency in the middle and the N-

terminus (Supplementary Materials Table 1S). It is a consensus that ACE
contains three binding pockets (S1, S1′ , and S2′ ) involved in the hydro
lysis of angiotensin-I, thereby degrading bradykinin and increasing
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blood pressure (Caballero, 2020; Bernstein, et al., 2013). The positive
control (captopril) was used as a reference to assess the molecular
docking (Supplementary Materials Table 1S) holding interactions with
active sites (S1) and (S2) interacting with residues PHE457 and PHE527
as shown in other studies (Hall, et al., 2020). CSP-SGD inhibited ACE by
multiple bonds and hydrophobic interactions with residues ALA354,
VAL379/380, GLU162, HIS353/383, at the active site (S1), HIS353/513,
and LYS511 at the active site (S2′ ), and interaction with ZN(II) and
reactive GLU384 in HEXXH zinc-binding motif (Table 1). The interac
tion with the S2′ pocket (HIS-313, HIS-353, TYR523, ALA 354) was
frequent in this study. Similar results were observed by Xu et al. (2021),
where hydrolyzed peptides derived from soybean (including IY, WMY,
YVVF and LVLL) showed ACE inhibitory activity by forming H-bonds
with HIS353 and HIS513 in S2 active pocket of ACE. S2′ residues are
involved in orienting the amide nitrogen in the substrate to accept hy
drogens produced from nucleophilic attack of water by GLU3, which
scissile amide nitrogen in the substrate facilitating cleavage.
Even though some peptides derived from CSP-SGD hold interactions
with the active site of ACE, the kinetic observations indicated a noncompetitive type inhibition. We hypothesized that a higher participa
tion of glutamine-rich peptides with zinc ions might account for the
observed activities from CSP-SGD on ACE. Since ACE is a zinc dependent
dipeptidyl carboxypeptidase (Ianzer et al., 2007), zinc ions are key in the
function of ACE. Therefore, Zn (II) interaction could impart noncompetitive inhibitor attributes. For example, Ni, et al. (2012) identi
fied a hexapeptide (TPTQQS) that acted as a non-competitive inhibitor.
They demonstrated how the interaction of glutamine could convey noncompetitive characteristics to a peptide by forcing the zinc ion away

from the active site and potentially triggering an active site conforma
tion change. Our study also determined the interaction of glutaminecontaining peptides QTPHQ and ELHPQ with Zn (II) coordination and
could explain the non-competitive inhibition observed during the
enzyme kinetics analysis. Consequently, future studies could be directed
to understand quantitatively the presence of glutamine motifs of
expression in canary seed proteins, and their correlation with ACE
inhibition.
3.5. Identification and molecular docking analysis of CSP-SGD with
pancreatic lipase inhibition
Based on affinity binding scores determined by molecular docking,
the following four peptide sequences (VPPR, LADR, LSPR, and TVGPR)
were identified as having the potential inhibitory activity towards
pancreatic lipase. Table 1 shows the four peptides had negative GRAVY
scores (− 0.9 to − 0.6) indicating intermediate hydrophobicity and
binding energies (Affinity Energy) of (− 6.2 to − 5.9 kJ/mol), and
interacting mainly with 11 residues from the binding interaction inter
phase of the pancreatic lipase and colipase domains. The positive control
(orlistat) was used as a reference for molecular docking holding in
teractions (Supplementary Materials Table 2S) with active site residues
SER153, HIS152, and HIS264 as reported in previous studies (Kokotos,
2003; Martinez-Gonzalez, et al., 2017). These interactions were found
mainly to be by hydrogen bonding, followed by salt bridges and hy
drophobic bonding (Fig. 5). At the access date for this study, a database
search of CSP-SGD using the BIOPEP-UWM online server (http://www.
uwm.edu.pl/biochemia/index.php/en/biopep, accessed 5/18/2021),

Fig. 5. Interaction of four canary seed peptide sequences (A-D) with the highest binding energy towards pancreatic lipase-colipase complex (1ETH).
8

U. Urbizo-Reyes et al.

Journal of Functional Foods 88 (2022) 104892

showed no matches to any pancreatic lipase inhibitory peptides (Min
kiewicz, Iwaniak, & Darewicz, 2019). Some common validated
pancreatic lipase inhibitory peptides identified in the search included:
YGNPVGGVGH, RLARAGLAQ, LAPSTIK, and VAPEEHPV. Additionally,
no structural motifs were identified between these peptides and the ones
reported in this study. The limited information (only 18 antiobesity
peptides have been reported in the database) and the insufficient data
available on how peptides inhibit pancreatic lipase limits the database
search and evidence the gap in research on the mechanisms of action of
biopeptides against this enzyme. Nevertheless, studies on camel (Cam
elus dromedarius) milk (Mudgil et al., 2018), cocoa bean (Theobroma
cacao L.) (Coronado-Cáceres et al., 2020), yellow field pea (Pisum sat
ivum L.) (Awosika & Aluko, 2019), and pinto beans (Phaseolus vulgaris)
(Ngoh, Choi, & Gan, 2017) provide insights on the understanding of the
peptides’ structural motifs and evidence the effect of non-polar residues
to establish complex interactions with the lipophilic enzyme.
The molecular docking analysis revealed a higher rate of interaction
of arginine with residues involved in keeping pancreatic lipase active.
Although recent evidence shows that arginine-rich peptides might act as
pancreatic lipase inhibitors (Stefanucci et al., 2019), their specific
mechanism of action remains to be understood.
It is well recognized that pancreatic lipase largely contributes to the
digestion of dietary fats, yielding small polar β–monoglycerides and
fatty acids (Haque & Prabhu, 2016). During this process, pancreatic
lipase activation occurs at the site where a 23-amino acid surface loop
called “lid” (stretched from CYS238 and CYS262) is removed from the
active site constituted by SER153, ASP177, and HIS264 in a four-step
process (Haque & Prabhu, 2016). In this respect, ASP248, ASP250 and
ASP258 residues are responsible for initiating lid movements during step
1 (S1) by coulombic forces, causing salt bridge bonds of ARG257 and
ASP80 and H-bonds between ARG258 and TYR268 to be broken, helping
to stabilize the open conformation of the lid (Haque & Prabhu, 2016).
The four peptides could interfere with S1 interacting via hydrogen and
salt bridges holding multiple bonds at a time with lipase and colipase
residues (ASP248, ASP250, ASP258) (Table 1, Fig. 5). The interference
of these peptides with CYS238 and LYS240 is associated with possible
destabilization of disulfide bonds in step 2 (S2), where the separated lid
is connected to the domain 1 (residues 1–336 of pancreatic lipase
structure) via disulfide bonds with CYS238 (Table 1). On the other hand,
peptide bonding to GLY237 and ILE249 may play an important role in
steps 3 (S3) and 4 (S4), interfering with lid flexibility and reducing
molecular mobility in the final step of the enzyme activation (Haque &
Prabhu, 2016). Furthermore, peptides containing glycine interacted
with GLU13 and GLU15 colipase’s residues, and could block the lid
conformation to return to its open state, thus preventing lipase from
triggering further hydrolysis (Moreno-Córdova et al., 2020). The inter
ference with the lid opening (S1-S4) and colipase corroborates the un
competitive behavior observed in the kinetic analysis in this study
(Fig. 2). Within the peptides that showed lipase inhibition, we identified
that they had an exceptionally high content of hydrophobic amino acids
(proline, leucine, and glycine) (Supplementary Materials Table 2S).
More importantly arginine in the C-terminal of CSP-SGD showed to be
the most relevant structural motif of inhibition (Fig. 5). In this context,
we discovered that the frequency of interaction of hydrophobic amino
acids from CSP-SGD with residues involved in stabilizing the active state
of pancreatic lipase was 28%, lower than that observed for arginine
alone (41%). This suggests that their primary role is to serve as stabi
lizing anchor points during enzyme-peptide interactions, where hydro
phobic bonds are likely needed. Subsequently, exploring protein sources
with high arginine content might be relevant in discovering novel lipase
inhibitors.

digestion (CSP-SGD), maintaining their bioactivity for ACE and DPP-IV,
while enhancing it for pancreatic lipase. Kinetic analysis by LineweaverBurk plots revealed that CSP-SGD inhibit enzymes by mixed-type inhi
bition for DPP-IV and α-glucosidase; non-competitive inhibition for ACE;
and uncompetitive inhibitor for pancreatic lipase. The peptide fractions,
particularly fractions F5 and F7, also exhibited > 10% transport yield
across the Caco-2 monolayer, suggesting that the peptides can have
optimal transport through the epithelium.
For the first time, novel peptides sequences with potential antihy
pertensive (LHPQ, QTPHQ, KPVPR, and ELHPQ) and antiobesity (VPPR,
LADR, LSPR, and TVGPR) activity were identified from canary seed
protein. Molecular docking analysis revealed the importance of argi
nine, glycine, and hydrophobic amino acids in CSP-SGD, and their pri
mary role in disrupting the proper function of the pancreatic lipase lid
domain (CYS238-CYS262). Conversely, ACE inhibitory peptides were
rich in proline, glutamine, and cationic residues, and could inhibit ACE
by destabilization of the tetrahedral transition state, and zinc ions
interaction leading to conformational changes. Taken together, these
results suggest that canary seed peptides could serve as a promising
therapeutic alternative and/or as functional, nutraceutical ingredients,
even after gastrointestinal digestion. Future studies implementing pep
tide synthesis and molecular dynamics simulations will be valuable to
validate the role of specific amino acids in the inhibition of enzymes
such as ACE and pancreatic lipase. Finally, research should be geared
towards understanding and assessing the health benefits and metabolic
consequences of canary seed bioactive peptides in vivo.
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4. Conclusions
In the present work, we determined that canary seed biopeptides
produced with Alcalase remained stable after simulated gastrointestinal
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